About Christopher Cox
Christopher Cox filed with the SEC as director and 10% owner of Scientific Industries from 2020 to 2024.
Form D filings name Christopher Cox as a general counsel at Areteia Therapeutics.
Christopher Cox reports to the SEC as a director, officer or major shareholder of 5 public companies, including Invivyd (IVVD), Population Health Investment Co. (PHIC) and Medicines (MDCO).
Christopher Cox first appears on SEC filings in 2012.
Experience
This experience comes from SEC filings. The years are when the filings name Christopher Cox in the role, so the role may have started earlier or lasted longer.
SI
Scientific Industries Inc.
Director and 10% owner
2020 – 2024 · Public company (SCND)
II
Invivyd, Inc.
Reporting person
2022 · Public company (IVVD)
PI
Population Health Investment Co., Inc.
Senior Vice President
2020 · Public company (PHIC)
MC
Medicines Co.
EVP & Chief Corp. Dev. Officer
2016 – 2019 · Public company (MDCO)
DC
Datawatch Corp.
Director
2012 – 2018 · Public company (DWCH)
Key Colleagues at Startups
The people Christopher Cox works with at each company, as listed on that company's latest Form D.
Areteia Therapeutics, Inc. · Form D, Jul 14, 2022
JB
Jorge Bartolome
Director
CV
Chris Visioli
Executive officer
SB
Stephen Butts
Director
BG
Benjamin Gomez
Director
AK
Adam Koppel
Director
IR
Ian Read
Director
PB
Paul Berns
Director
WB
Whit Bernard
Executive officer
MB
Michael Bozik
Director